Compare PBYI & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PBYI | SPIR |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 343.9M | 826.5M |
| IPO Year | 2011 | 2020 |
| Metric | PBYI | SPIR |
|---|---|---|
| Price | $7.00 | $20.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $16.40 |
| AVG Volume (30 Days) | 234.0K | ★ 1.6M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 134.98 |
| EPS | ★ N/A | N/A |
| Revenue | $27,685,000.00 | ★ $110,451,000.00 |
| Revenue This Year | N/A | $12.31 |
| Revenue Next Year | N/A | $22.63 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 13.15 |
| 52 Week Low | $3.03 | $6.60 |
| 52 Week High | $7.90 | $25.93 |
| Indicator | PBYI | SPIR |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 52.10 |
| Support Level | $6.32 | $8.16 |
| Resistance Level | $7.31 | $24.76 |
| Average True Range (ATR) | 0.24 | 2.28 |
| MACD | -0.02 | -0.21 |
| Stochastic Oscillator | 48.48 | 35.25 |
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
Spire Global Inc provides space-based data, analytics, and space services, offering datasets and insights about Earth to support decision-making. It builds, owns, and operates a constellation of nanosatellites that observe the Earth in real time using radio frequency (RF) technology. Additionally, it offers Space Services solutions that allow customers to deploy and scale their own satellite constellations using its platform, ground station network, manufacturing facilities, and launch partnerships. The company derives revenue from providing data, insights and access to its cloud-based technology platform sold on a subscription basis.